NCT00281580View on ClinicalTrials.gov

Telmisartan (Micardis) and Amlodipine (Norvasc) - Factorial Design Study for the Treatment of Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

1,461

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

March 31, 2007

Conditions
Hypertension
Interventions
DRUG

Amlodipine 5 mg

Amlodipine 5 mg once daily for two weeks

DRUG

Placebo

Placebo to Telmisartan and Amlodipine once daily for eight weeks

DRUG

Telmisartan 20 mg

Telmisartan 20 mg once daily for eight weeks

DRUG

Telmisartan 40 mg

Telmisartan 40 mg once daily for eight weeks

DRUG

Amlodipine 10 mg

Amlodipine 10 mg once daily for six weeks

DRUG

Telmisartan 20 mg

Telmisartan 20 mg once daily for eight weeks

DRUG

Telmisartan 80 mg

Telmisartan 80 mg once daily for eight weeks

DRUG

Amlodipine 10 mg

Amlodipine 10 mg once daily for six weeks

DRUG

Telmisartan 20 mg

Telmisartan 20 mg once daily for eight weeks

DRUG

Amlodipine 5 mg

Amlodipine 5 mg once daily for two weeks

DRUG

Amlodipine 5 mg

amlodipine 5g once daily for eight weeks

DRUG

Telmisartan 20 mg

Telmisartan 20 mg once daily for eight weeks

DRUG

Amlodipine 5 mg

Amlodipine 5 mg once daily for eight weeks

DRUG

Amlodipine 5 mg

amlodipine 5mg once daily for eight weeks

DRUG

Amlodipine 2.5 mg

Amlodipine 2.5 mg once daily for eight weeks

DRUG

Amlodipine 2.5 mg

Amlodipine 2.5 mg once daily for eight weeks

DRUG

Amlodipine 10 mg

Amlodipine 10 mg once daily for six weeks

DRUG

Amlodipine 2.5 mg

Amlodipine 2.5 mg once daily for eight weeks

DRUG

Telmisartan 80 mg

Telmisartan 80 mg once daily for eight weeks

DRUG

Telmisartan 80 mg

Telmisartan 80 mg once daily for eight weeks

DRUG

Amlodipine 5 mg

Amlodipine 5 mg once daily for two weeks

DRUG

Amlodipine 2.5 mg

Amlodipine 2.5 mg once daily for eight weeks

DRUG

Telmisartan 40 mg

Telmisartan 40 mg once daily for eight weeks

DRUG

Telmisartan 40 mg

Telmisartan 40 mg once daily for eight weeks

DRUG

Amlodipine 5 mg

amlodipine 5g once daily for two weeks

DRUG

Amlodipine 5 mg

Amlodipine 5 mg once daily for eight weeks

DRUG

Telmisartan 40 mg

Telmisartan 40 mg once daily for eight weeks

DRUG

Telmisartan 80 mg

Telmisartan 80 mg once daily for eight weeks

DRUG

Amlodipine 10 mg

Amlodipine 10 mg once daily for six weeks

Trial Locations (136)

Unknown

1235.1.457 Boehringer Ingelheim Investigational Site, Fairhope

1235.1.368 Boehringer Ingelheim Investigational Site, Huntsville

1235.1.389 Boehringer Ingelheim Investigational Site, Huntsville

1235.1.411 Boehringer Ingelheim Investigational Site, Huntsville

1235.1.429 Boehringer Ingelheim Investigational Site, Chandler

1235.1.420 Boehringer Ingelheim Investigational Site, Tempe

1235.1.391 Boehringer Ingelheim Investigational Site, Cudahy

1235.1.444 Boehringer Ingelheim Investigational Site, Encinitas

1235.1.445 Boehringer Ingelheim Investigational Site, Encino

1235.1.357 Boehringer Ingelheim Investigational Site, Long Beach

1235.1.465 Boehringer Ingelheim Investigational Site, Los Angeles

1235.1.441 Boehringer Ingelheim Investigational Site, Riverside

1235.1.409 Boehringer Ingelheim Investigational Site, Sacramento

1235.1.406 Boehringer Ingelheim Investigational Site, San Diego

1235.1.414 Boehringer Ingelheim Investigational Site, Santa Ana

1235.1.383 Boehringer Ingelheim Investigational Site, Spring Valley

1235.1.395 Boehringer Ingelheim Investigational Site, Tustin

1235.1.453 Boehringer Ingelheim Investigational Site, Milford

1235.1.394 Boehringer Ingelheim Investigational Site, Newark

1235.1.354 Boehringer Ingelheim Investigational Site, Cooper City

1235.1.451 Boehringer Ingelheim Investigational Site, DeLand

1235.1.372 Boehringer Ingelheim Investigational Site, Fort Lauderdale

1235.1.396 Boehringer Ingelheim Investigational Site, Fort Lauderdale

1235.1.390 Boehringer Ingelheim Investigational Site, Hialeah

1235.1.430 Boehringer Ingelheim Investigational Site, Kissimmee

1235.1.351 Boehringer Ingelheim Investigational Site, Melbourne

1235.1.398 Boehringer Ingelheim Investigational Site, Melbourne

1235.1.405 Boehringer Ingelheim Investigational Site, Mirimar

1235.1.352 Boehringer Ingelheim Investigational Site, Pembroke Pines

1235.1.369 Boehringer Ingelheim Investigational Site, Pembroke Pines

1235.1.397 Boehringer Ingelheim Investigational Site, Pembroke Pines

1235.1.449 Boehringer Ingelheim Investigational Site, Pensacola

1235.1.355 Boehringer Ingelheim Investigational Site, Rockledge

1235.1.407 Boehringer Ingelheim Investigational Site, Tampa

1235.1.380 Boehringer Ingelheim Investigational Site, Tucker

1235.1.438 Boehringer Ingelheim Investigational Site, Gurnee

1235.1.373 Boehringer Ingelheim Investigational Site, Evansville

1235.1.375 Boehringer Ingelheim Investigational Site, Evansville

1235.1.415 Boehringer Ingelheim Investigational Site, Indianapolis

1235.1.412 Boehringer Ingelheim Investigational Site, South Bend

1235.1.435 Boehringer Ingelheim Investigational Site, Arkansas City

1235.1.379 Boehringer Ingelheim Investigational Site, Lenexa

1235.1.421 Boehringer Ingelheim Investigational Site, Newtown

1235.1.356 Boehringer Ingelheim Investigational Site, Wichita

1235.1.423 Boehringer Ingelheim Investigational Site, Louisville

1235.1.387 Boehringer Ingelheim Investigational Site, North Dartmouth

1235.1.424 Boehringer Ingelheim Investigational Site, Bay City

1235.1.385 Boehringer Ingelheim Investigational Site, Florissant

1235.1.452 Boehringer Ingelheim Investigational Site, Florissant

1235.1.365 Boehringer Ingelheim Investigational Site, Kansas City

1235.1.431 Boehringer Ingelheim Investigational Site, Kansas City

1235.1.454 Boehringer Ingelheim Investigational Site, Henderson

1235.1.426 Boehringer Ingelheim Investigational Site, Cherry Hill

1235.1.434 Boehringer Ingelheim Investigational Site, Stratford

1235.1.366 Boehringer Ingelheim Investigational Site, East Syracuse

1235.1.377 Boehringer Ingelheim Investigational Site, Northport

1235.1.427 Boehringer Ingelheim Investigational Site, Rochester

1235.1.381 Boehringer Ingelheim Investigational Site, Williamsville

1235.1.410 Boehringer Ingelheim Investigational Site, Burlington

1235.1.400 Boehringer Ingelheim Investigational Site, Charlotte

1235.1.422 Boehringer Ingelheim Investigational Site, Greenboro

1235.1.403 Boehringer Ingelheim Investigational Site, Lenior

1235.1.376 Boehringer Ingelheim Investigational Site, Raleigh

1235.1.392 Boehringer Ingelheim Investigational Site, Raleigh

1235.1.384 Boehringer Ingelheim Investigational Site, Winston-Salem

1235.1.458 Boehringer Ingelheim Investigational Site, Winston-Salem

1235.1.374 Boehringer Ingelheim Investigational Site, Columbus

1235.1.446 Boehringer Ingelheim Investigational Site, Columbus

1235.1.413 Boehringer Ingelheim Investigational Site, Marion

1235.1.359 Boehringer Ingelheim Investigational Site, Oklahoma City

1235.1.361 Boehringer Ingelheim Investigational Site, Oklahoma City

1235.1.436 Boehringer Ingelheim Investigational Site, Oklahoma City

1235.1.448 Boehringer Ingelheim Investigational Site, Oklahoma City

1235.1.386 Boehringer Ingelheim Investigational Site, Tulsa

1235.1.439 Boehringer Ingelheim Investigational Site, Portland

1235.1.440 Boehringer Ingelheim Investigational Site, Portland

1235.1.408 Boehringer Ingelheim Investigational Site, Erie

1235.1.404 Boehringer Ingelheim Investigational Site, Lansdale

1235.1.428 Boehringer Ingelheim Investigational Site, Penndel

1235.1.370 Boehringer Ingelheim Investigational Site, East Providence

1235.1.433 Boehringer Ingelheim Investigational Site, Beaufort

1235.1.462 Boehringer Ingelheim Investigational Site, Union

1235.1.417 Boehringer Ingelheim Investigational Site, Cordova

1235.1.459 Boehringer Ingelheim Investigational Site, Jackson

1235.1.363 Boehringer Ingelheim Investigational Site, New Tazewell

1235.1.382 Boehringer Ingelheim Investigational Site, Selmer

1235.1.442 Boehringer Ingelheim Investigational Site, Austin

1235.1.399 Boehringer Ingelheim Investigational Site, Carrollton

1235.1.460 Boehringer Ingelheim Investigational Site, Dallas

1235.1.443 Boehringer Ingelheim Investigational Site, Georgetown

1235.1.416 Boehringer Ingelheim Investigational Site, Killeen

1235.1.402 Boehringer Ingelheim Investigational Site, Lake Jackson

1235.1.432 Boehringer Ingelheim Investigational Site, McKinney

1235.1.456 Boehringer Ingelheim Investigational Site, Odessa

1235.1.418 Boehringer Ingelheim Investigational Site, Plano

1235.1.455 Boehringer Ingelheim Investigational Site, Waco

1235.1.358 Boehringer Ingelheim Investigational Site, Salt Lake City

1235.1.464 Boehringer Ingelheim Investigational Site, Salt Lake City

1235.1.437 Boehringer Ingelheim Investigational Site, Burke

1235.1.447 Boehringer Ingelheim Investigational Site, Fredericksburg

1235.1.371 Boehringer Ingelheim Investigational Site, Tacoma

1235.1.001 Boehringer Ingelheim Investigational Site, BsAs

1235.1.004 Boehringer Ingelheim Investigational Site, Buenos Aires

1235.1.005 Boehringer Ingelheim Investigational Site, Buenos Aires

1235.1.006 Boehringer Ingelheim Investigational Site, Buenos Aires

1235.1.002 Boehringer Ingelheim Investigational Site, Carlos Paz

1235.1.003 Boehringer Ingelheim Investigational Site, Córdoba

1235.1.115 Universidade Federal do Pará, Belém

1235.1.102 Liga de Hipertensão Arterial, Goiânia

1235.1.101 Clínica Médica, Rio de Janeiro

1235.1.103 Unidade de Hipertensão - ICHC -, São Paulo

1235.1.109 Centro de Pesquisas do Hospital do Rim e Hipertensão, São Paulo

1235.1.203, Col. Magdalena de Las Salinas

1235.1.210 Consultorio Privado, Durango, Durango

1235.1.202, Guadalajara, Jalisco

1235.1.209 Boehringer Ingelheim Investigational Site, Guadalajara, Jalisco

1235.1.204, Lomas de Guevara, Guadalajara

"1235.1.208 Ignacio Chávez", Mexico City

1235.1.211 Obesidad Y Prevencion de Enfermedades, Mexico City

1235.1.212 en Factores de riesgo cardiovascular, México

1235.1.205 Fraccionamiento Industrias, San Luis Potosí City

1235.1.207, Zapopan, Jalisco

1235.1.314 Boehringer Ingelheim Investigational Site, Benoni

1235.1.302 Boehringer Ingelheim Investigational Site, Boksburg

1235.1.306 Boehringer Ingelheim Investigational Site, Cape Town

1235.1.309 Boehringer Ingelheim Investigational Site, Cape Town

1235.1.310 Boehringer Ingelheim Investigational Site, Cape Town

1235.1.311 Boehringer Ingelheim Investigational Site, Cape Town

1235.1.304 Boehringer Ingelheim Investigational Site, Durban

1235.1.312 Boehringer Ingelheim Investigational Site, Johannesburg

1235.1.313 Boehringer Ingelheim Investigational Site, Johannesburg

1235.1.307 Boehringer Ingelheim Investigational Site, Krugersdorp

1235.1.303 Boehringer Ingelheim Investigational Site, Lenasia

1235.1.305 Boehringer Ingelheim Investigational Site, Lenasia

1235.1.301 Boehringer Ingelheim Investigational Site, Pretoria

1235.1.308 Boehringer Ingelheim Investigational Site, Pretoria

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY